Evolent Health, Inc.
Symbole: EVH
NYSE
31.93
USDPrix du marché aujourd'hui
-27.2314
Ratio P/E
0.0238
Ratio PEG
3.69B
Cap MRK
- 0.00%
Rendement DIV
Evolent Health, Inc. (EVH) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 677.41 | 192.8 | 188.2 | 266.3 | ||||||||||||
balance-sheet.row.short-term-investments | 118.9 | 13.8 | 14.5 | 75.7 | ||||||||||||
balance-sheet.row.net-receivables | 1480.17 | 446.7 | 254.7 | 130.6 | ||||||||||||
balance-sheet.row.inventory | -816.51 | 0 | -415.9 | -308.2 | ||||||||||||
balance-sheet.row.other-current-assets | 1020.3 | 30.3 | 451.1 | 435.3 | ||||||||||||
balance-sheet.row.total-current-assets | 2375.14 | 683.7 | 478.1 | 524 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 431.5 | 90.2 | 136.9 | 131.6 | ||||||||||||
balance-sheet.row.goodwill | 4469.59 | 1116.5 | 722.8 | 426.3 | ||||||||||||
balance-sheet.row.intangible-assets | 3157.46 | 752 | 442.8 | 279.8 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 7627.04 | 1868.6 | 1165.6 | 706.1 | ||||||||||||
balance-sheet.row.long-term-investments | 18.13 | 4.9 | 4.5 | 5.5 | ||||||||||||
balance-sheet.row.tax-assets | 25.53 | 12.1 | 0 | 39.4 | ||||||||||||
balance-sheet.row.other-non-current-assets | 108.87 | 20.9 | 32.3 | 13 | ||||||||||||
balance-sheet.row.total-non-current-assets | 8211.07 | 1996.6 | 1339.2 | 895.5 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 10586.21 | 2680.3 | 1817.3 | 1419.5 | ||||||||||||
balance-sheet.row.account-payables | 227.99 | 48.2 | 57.2 | 96.1 | ||||||||||||
balance-sheet.row.short-term-debt | 34.52 | 9.7 | 7.1 | 7.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 2596.52 | 635.1 | 469 | 273.4 | ||||||||||||
Deferred Revenue Non Current | 763.39 | 583.7 | 2.5 | 4.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 330.46 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 1593.18 | 610.3 | 363.4 | 330.4 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 3982.56 | 938.4 | 524.4 | 280.3 | ||||||||||||
balance-sheet.row.other-liabilities | 343.45 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 222.04 | 47.7 | 63.1 | 64.8 | ||||||||||||
balance-sheet.row.total-liab | 6207.46 | 1612.6 | 957.9 | 725.8 | ||||||||||||
balance-sheet.row.preferred-stock | 1695.41 | 178.4 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 345.76 | 1.2 | 1 | 0.9 | ||||||||||||
balance-sheet.row.retained-earnings | -2691.57 | -719.2 | -606.2 | -626.8 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -4.76 | -1.3 | -1.2 | -0.4 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 5033.92 | 1608.6 | 1465.7 | 1319.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 4378.76 | 1067.7 | 859.4 | 693.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 10586.21 | 2680.3 | 1817.3 | 1419.5 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 4378.76 | 1067.7 | 859.4 | 693.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 10586.21 | - | - | - | ||||||||||||
Total Investments | 119.15 | 4.9 | 19 | 5.5 | ||||||||||||
balance-sheet.row.total-debt | 2626.43 | 644.8 | 476.1 | 280.5 | ||||||||||||
balance-sheet.row.net-debt | 1949.02 | 452 | 287.9 | 14.2 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -113.04 | -113 | -19.2 | -37.6 | |||||||||||
cash-flows.row.depreciation-and-amortization | 125.7 | 123.4 | 67.2 | 60 | |||||||||||
cash-flows.row.deferred-income-tax | -97.46 | -31.3 | 0.3 | -0.5 | |||||||||||
cash-flows.row.stock-based-compensation | 40.5 | 40.5 | 34 | 16.7 | |||||||||||
cash-flows.row.change-in-working-capital | 67.77 | 21.9 | -104.4 | -13.6 | |||||||||||
cash-flows.row.account-receivables | -164.69 | -164.7 | -103 | -5.8 | |||||||||||
cash-flows.row.inventory | 0 | -10.7 | 0 | -14.1 | |||||||||||
cash-flows.row.account-payables | -6.72 | -6.7 | 13.2 | 7.3 | |||||||||||
cash-flows.row.other-working-capital | 232.94 | 204.1 | -14.6 | -1 | |||||||||||
cash-flows.row.other-non-cash-items | 119.11 | 101.1 | 10.5 | 13.8 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 142.58 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -28.75 | -28.7 | -38.4 | -25 | |||||||||||
cash-flows.row.acquisitions-net | -388.25 | 0.9 | 5.6 | -34.8 | |||||||||||
cash-flows.row.purchases-of-investments | 387.45 | -0.9 | -5.6 | -3 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0.87 | 0.9 | 5.6 | 0.5 | |||||||||||
cash-flows.row.other-investing-activites | -387.74 | -387.7 | -226.3 | 46.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -415.54 | -415.5 | -259.1 | -15.8 | |||||||||||
cash-flows.row.debt-repayment | -464.47 | -464.2 | -219.7 | -98.8 | |||||||||||
cash-flows.row.common-stock-issued | 7.6 | 479.5 | 4.5 | 13.3 | |||||||||||
cash-flows.row.common-stock-repurchased | -15.29 | -15.3 | -18.3 | -3.9 | |||||||||||
cash-flows.row.dividends-paid | -18.79 | -18.8 | -14.9 | -1.3 | |||||||||||
cash-flows.row.other-financing-activites | 772.29 | 300.1 | 380 | 61.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 281.34 | 281.3 | 131.5 | -29.5 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.08 | -0.1 | -0.7 | -0.1 | |||||||||||
cash-flows.row.net-change-in-cash | 8.3 | 8.3 | -139.8 | -6.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 847.52 | 223.5 | 215.2 | 354.9 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 839.23 | 215.2 | 354.9 | 361.6 | |||||||||||
cash-flows.row.operating-cash-flow | 142.58 | 142.6 | -11.6 | 38.7 | |||||||||||
cash-flows.row.capital-expenditure | -28.75 | -28.7 | -38.4 | -25 | |||||||||||
cash-flows.row.free-cash-flow | 113.84 | 113.8 | -49.9 | 13.8 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1963.9 | 1963.9 | 1352 | 908 | ||||||||||||
income-statement-row.row.cost-of-revenue | 1503.43 | 1503.4 | 1035.4 | 657.6 | ||||||||||||
income-statement-row.row.gross-profit | 460.47 | 460.5 | 316.6 | 250.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 26.7 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 360.23 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 34955.47 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 33.15 | -62.5 | 67.2 | 60 | ||||||||||||
income-statement-row.row.operating-expenses | 481.52 | 481.5 | 336.5 | 279.5 | ||||||||||||
income-statement-row.row.cost-and-expenses | 1984.95 | 1985 | 1371.9 | 937.1 | ||||||||||||
income-statement-row.row.interest-income | 5.26 | 5.3 | 1.4 | 0.4 | ||||||||||||
income-statement-row.row.interest-expense | 54.2 | 54.2 | 15.6 | 25.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 34955.47 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -144.24 | -132.4 | -2.2 | -60 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 33.15 | -62.5 | 67.2 | 60 | ||||||||||||
income-statement-row.row.total-operating-expenses | -144.24 | -132.4 | -2.2 | -60 | ||||||||||||
income-statement-row.row.interest-expense | 54.2 | 54.2 | 15.6 | 25.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 58.49 | 123.4 | 67.2 | 60 | ||||||||||||
income-statement-row.row.ebitda-caps | 46.38 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -62.64 | -71.2 | -59.8 | 30.2 | ||||||||||||
income-statement-row.row.income-before-tax | -202.41 | -202.4 | -62.1 | -29.8 | ||||||||||||
income-statement-row.row.income-tax-expense | -89.36 | -89.4 | -43.4 | 0.5 | ||||||||||||
income-statement-row.row.net-income | -113.04 | -113 | -18.7 | -30.3 |
Questions fréquemment posées
Quel est le total de Evolent Health, Inc. (EVH) de l'actif total?
Evolent Health, Inc. (EVH) Le total des actifs est 2680308000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 1067070000.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.234.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 1.002.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.058.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.032.
Qu'est-ce que Evolent Health, Inc. (EVH) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -113040000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 644796000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 481525000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 192825000.000.